Figure 5.

CaN inhibition by AKAP79 inhibitory peptide prevents TgCM-induced morphological abnormalities. Dendritic dystrophies (A), dendritic attenuation (B, C), and spine loss (D) in wild-type cultured neurons growing in TgCM are significantly prevented by CaN inhibitory peptide AKAP79. *p < 0.05 in C (TgCM with AKAP79 vs TgCM with vector). **p < 0.01. Data are mean ± SD from three independent experiments in triplicate. E–H, CaN inhibition by AKAP79 inhibitory peptide prevents APP overexpression-induced morphological abnormalities. In Tg cultures at 21 DIV, dendritic dystrophies (E), dendritic attenuation (F, G), and spine loss (H) are prevented by CaN inhibitory peptide AKAP79. *p < 0.05 in G (Tg with AKAP79 vs Tg with vector). Data are mean ± SD from three independent experiments, each in triplicate.